Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-16-013725
Filing Date
2016-12-21
Accepted
2016-12-20 17:31:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 f424b5_122016.htm 424B5 670967
2 GRAPHIC logo.jpg GRAPHIC 7332
3 GRAPHIC pipeline.jpg GRAPHIC 185709
  Complete submission text file 0001171843-16-013725.txt   937637
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B5 | Act: 33 | File No.: 333-209702 | Film No.: 162062250
SIC: 2834 Pharmaceutical Preparations